Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

NCT00975221 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperparathyroidism, Primary
Hypercalcemia

Interventions

DRUG: Cinacalcet
DRUG: Placebo

Sponsor

Amgen